MYNZEPLI 40 mg/mL solution for injection in a vial
*Company:
ADVANZ PharmaStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
Aflibercept_Patient_Guide_EnglishIE_Pickups_4_F.wav
Reasons for updating
- Add New Audio
File name
Advanz Mynzepli_Prescriber guide video_Ireland_v3.mp4
Reasons for updating
- Add New Video
File name
1. Advanz MYNZEPLI IE Administration guide (RMM)_Approved.pdf
Reasons for updating
- Add New Doc
File name
2. Advanz MYNZEPLI IE Patient guide (RMM)_Approved.pdf
Reasons for updating
- Add New Doc
Updated on 07 November 2025
File name
MYNZEPLI 40 mgmL solution for injection in a vial-SPC.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 07 November 2025
File name
MYNZEPLI 40 mgmL solution for injection in a vial_PIL.pdf
Reasons for updating
- New PIL for new product
ADVANZ Pharma
Address:
Unit 17 Northwood House Northwood Crescent Northwood, Dublin 9, D09 V504, IrelandMedical Information E-mail:
medicalinformation@advanzpharma.comTelephone:
+44 (0)208 588 9131Website:
https://www.advanzpharma.comMedical Information Direct Line:
+353 1800 851 119Customer Care direct line:
+353 1 5294 230